Nature, Published online: 18 September 2025; doi:10.1038/d41586-025-03000-zAlterEgo’s neural-interface device is non-invasive and is being tested in people with multiple sclerosis and amyotrophic lateral sclerosis. Read original aricle: Read More
Discover more from DrWeb's Domain
Subscribe to get the latest posts sent to your email.
